Longitudinal study analyzes antibody responses to sars-cov-2 in children, suggesting age and vaccination impact outcomes.
The majority of children experience severe acute respiratory syndrome coronavirus-2 infection as a mild infection. In this longitudinal single-center study of children infected early in the pandemic and managed as outpatients, we assess the impact of age, vaccination, recurrent infection and initial symptoms on severe acute respiratory syndrome coronavirus-2-specific antibody responses over time.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: